🔗 Share this article

Chancellor Reeves has announced she is planning "targeted measures to address household expense pressures" in the forthcoming financial statement.

In comments to media outlets, she noted that reducing price rises is a joint task of both the administration and the Bank of England.

The UK's inflation rate is forecast to be the highest among the G7 industrialized countries this calendar year and the following year.

Potential Energy Cost Interventions

Sources suggest the administration could take action to reduce utility costs, for instance by reducing the present 5% level of VAT charged on energy.

Another approach is to lower some of the regulatory levies presently added to bills.

Budgetary Constraints and Analyst Expectations

The administration will receive the latest report from the independent fiscal watchdog, the OBR, on Monday, which will show how much room there is for such measures.

The consensus from the majority of experts is that Reeves will have to introduce tax increases or expenditure reductions in order to meet her voluntary borrowing rules.

Previously on Thursday, analysis suggested there was a twenty-two billion pound gap for the Treasury chief to address, which is at the lower end of projections.

"There's a collective task between the Bank of England and the administration to continue tackling some of the causes of price increases," the Chancellor informed the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Tax Commitments and Global Issues

While much of the focus has been on probable tax increases, the chancellor said the latest information from the fiscal watchdog had not changed her vow to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with growing geopolitical and commercial issues for the Budget revenue measures, likely to be focused on those "wealthiest."

International Trade Tensions

Addressing apprehensions about the UK's economic relations with China she said: "Our security interests invariably take priority."

Recent announcement by Chinese authorities to increase trade restrictions on rare earths and other materials that are key for advanced tech production led US President the US President to threaten an further 100% tariff on imports from the Asian country, raising the risk of an full-scale trade war between the two economic giants.

The US Treasury Secretary labeled China's action "economic coercion" and "a international production control attempt."

Asked about accepting the US offer to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by China's measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the action was "harmful for the global economy and generates additional obstacles."

"I believe there are fields where we need to challenge China, but there are also important opportunities to sell into Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium right."

The Treasury chief also affirmed she was cooperating with other major economies "regarding our own critical minerals approach, so that we are more independent."

Health Service Medicine Pricing and Investment

The Chancellor also admitted that the cost the National Health Service spends on medicines could rise as a result of ongoing discussions with the US government and its drugs companies, in exchange for reduced taxes and funding.

Some of the biggest global drug companies have said recently that they are either delaying or scrapping operations in the United Kingdom, with some blaming the low prices they are obtaining.

Recently, the government science advisor said the price the NHS pays for medicines would need to rise to prevent businesses and pharmaceutical investment leaving the United Kingdom.

The Chancellor informed media: "We have seen because of the cost structure, that medical research, new drugs have not been provided in the UK in the way that they are in other continental states."

"The objective is to ensure that patients receiving care from the NHS are can receive the top essential drugs in the world. And so we are reviewing this situation, and... seeking to attract increased investment into Britain."